Background: Mass-forming focal pancreatitis (FP) may mimic pancreatic cancer (PC) on magnetic resonance (MR) imaging, and the preoperative differential diagnosis is often difficult. Recently, the usefulness of diffusion-weighted imaging (DWI) in the diagnosis of pancreatic cancer has been reported in several studies. Purpose: To investigate if apparent diffusion coefficient (ADC) measurements based on diffusion-weighted echo-planar imaging (DW-EPI) may distinguish between normal pancreas parenchyma, mass-forming focal pancreatitis, and pancreas carcinoma. Material and Methods: MRI was performed on 64 patients: 24 with pancreas carcinoma (PC), 20 with massforming focal pancreatitis (FP), three patients with other focal pancreatic disease as well as 17 controls without any known pancreatic disease. Diffusion-weighted sequence with ADC maps and T2-weighted sequence for anatomical information was performed. Apparent diffusion coefficient (ADC) maps were automatically created and analyzed using a dedicated user interface. In the group with pancreas disease the abnormal parenchyma was detected by using T1-and T2-weighted images and the region of interest (ROI) was transferred exactly to the ADC map and the coefficients were registered. In the control group the ROI was set to the head of the pancreas followed by a similar registration of the ADCs. Results: ADC values for mass-forming FP and PC differed significantly from ADC values for normal pancreas parenchyma (P ¼ 0.001/P ¼ 0.002). Mean ADC values for mass-forming FP were 0.69 + 0.18 Â 10 23 mm 2 /s.
Keywords: MRI, diffusion-weighted imaging, apparent diffusion coefficient, abdominal imaging, pancreas Submitted December 7, 2009; accepted for publication November 23, 2011 Magnetic resonance imaging (MRI) along with MR cholangiopancreatography (MRCP) have become the imaging modalities of choice to asses both the structure and the function of the pancreas. In addition, diffusion-weighted imaging (DWI) has been shown to provide useful information to discriminate between normal pancreas, pancreatitis, and pancreatic cancer (1) . Diffusion-weighted MRI and apparent diffusion coefficient (ADC) measurements have been applied to the abdomen (2) (3) (4) (5) . The results suggest that ADC measurements can be useful in the evaluation of diffuse liver (6) and renal diseases (7, 8) as well as for characterizing focal hepatic (4, 9), pancreatic (10) (11) (12) (13) (14) (15) , and renal (16) lesions. The purpose of our study was to evaluate DWI findings and measure the difference between ADC values of normal pancreas parenchyma, mass-forming focal pancreatitis (FP) and pancreas carcinoma (PC). We chose these pathologic conditions, as differentiation between them can be difficult. As there is a wide range of reported ADC values (10, 17, 18) for PC and mass-forming FP we had to establish our own reference values. Our aim was to test whether there is a significant difference in ADCs for normal pancreas and abnormal pancreas parenchyma (PC and mass-forming FP), as well as to test whether or not it is possible to differentiate between PC and massforming FP by using ADC measurements. This would allow us to establish a non-invasive imaging of pancreatic lesions protocol in the clinical routine to differentiate between PC and mass-forming FP.
Material and Methods

Patients
In this prospective study 64 subjects were included. Informed consent was obtained from all participants. The PC group was composed of 24 patients (12 women and 12 men; age range 38-81 years, mean age 64 years) with histological proof of ductal adenocarcinoma (PC) through Whipple procedure. Twenty patients (7 women and 13 men, age range 15 -74 years, mean age 52 years) were included in the mass-forming FP group. Sixteen of these patients underwent surgery because malignancy could not be ruled out by either imaging or fine-needle aspiration.
In four patients mass-forming FP was diagnosed without histopathologic proof, based on repeated imaging (MRI or dynamic computed tomography) and clinical follow-up (13 -25 months) after the initial presentation. Seventeen subjects without any pancreatic disease (5 women and 12 men; age range 12 -78 years, mean age 45 years) were included as control group and had normal MRI/MRCP findings. All patients underwent the same imaging protocol for the diffusion-weighted imaging, and were scanned within 14 days prior to the surgery. Histological findings were determined from the records of our Department of Pathology. We had to exclude three patients from our study due to the following conditions: serous cyst adenoma (1), adenocarcinoma of unknown primary localization (1), and diffuse disease of intestine (measurement not possible) (1).
MR protocol
Diffusion-weighted sequence with ADC maps as well as the routine pancreatic MR imaging protocol for anatomical information were performed using a Magnetom Avanto 1.5 T scanner (Siemens Medical Solutions, Erlangen, Germany) and a commercially available cp body phased array coil. Diffusion-weighted images were acquired using a single-shot echo-planar imaging pulse sequence in expiration breath-hold. The following parameters were used for the axial DW-EPI sequence: matrix size of 144 Â 192, a field-of-view of 375 Â 500 ( pixel size 2.6 Â 2.6 mm), and a section thickness of 2.6 mm. The b factors used were 50 and 500 s/mm 2 . In addition the routine pancreatic MR imaging protocol for the patient group consisted of TRUE-FISP imaging sequences, non-contrast T1-weighted fat-suppressed and dynamic gadolinium-enhanced gradientecho imaging as well as magnetic resonance cholangiopancreatography (MRCP) and angiography (MRA). The ADC maps were automatically created and analyzed using a dedicated user interface (Leonardo, Siemens Medical Solutions, Erlangen, Germany). The pancreas lesions were detected using the T1-and T2-weighted images and the ROI was transferred exactly to the ADC map and the according coefficients were registered ( Figs. 1 and 2 ). In the control group the ROI was set to the head of the pancreas gland followed by a similar registration of the ADCs. In the diseased population ROIs ranged from 70 to 879 mm (mean 354 mm 2 ), whereas in the control group a fixed ROI of 100 mm 2 was used.
Image analysis
Consensus reading was performed by two experienced radiologists (15 years and 6 years of experience). ADCs were calculated on a workstation with dedicated software. Signal intensities on ADC maps were measured by using an operator-defined region of interest (ROI). ADCs were calculated for normal pancreas and focal lesions of the pancreas. The ROIs for the pancreas were circular. Pancreas vessels, the pancreatic duct and the common bile duct were left out of the ROI. At the time of ROI placement, the operator was aware of the location of the lesions and could refer to routine MR images and to the histopathological diagnosis. We examined patients with PC, mass-forming FP, and without pancreatic disease. In three patients with massforming FP and pancreatic pseudo cysts the ROI was placed outside these cystic lesions. ADC values of the control group were used to establish the normal values. The ROI within each lesion was circular and placed on the largest possible area, including necrotic parts. Mean ADCs of the two lesion types and mean values of healthy pancreatic tissue were compared.
Statistical analysis
The non-parametric Mann-Whitney U test was used to determine whether there was a significant difference between ADC values for normal pancreas, PC, and massforming FP. Fig. 3) .
ADC values of the pancreatic carcinoma proved to be significantly higher compared with those of the normal pancreatic tissue in healthy volunteers ( Table 2 ). The Mann-Whitney U test demonstrated a statistically significant difference (P ,0.001). ADC values of the mass-forming FP also proved to be significantly higher compared with those of the normal pancreatic tissue. The Mann-Whitney U test demonstrated a statistically significant difference compared with those of the normal pancreatic tissue albeit at a lower significance level (P , 0.002). There was no significant difference in ADCs between PC and mass-forming FP (P ¼ 0.15). The inter-observer agreement for ADC measurements was analyzed using the ICC method. A 'fair to good agreement' was obtained for the average ADC value of mass-forming FP (ICC ¼ 0.623). 'Excellent' inter-observer agreement was observed for the ADC values of PC and the control group (ICC ¼ 0.768 and ICC ¼ 0.823). 
Discussion
Pancreatic cancer is the third most common malignancy of the gastrointestinal tract; the incidence rate is estimated at about 10 new cases per 100,000 people per year. The main task in diagnostic imaging of the pancreas is the detection and differentiation of pancreatic lesions into malignant and benign (e.g. inflammatory) entities as well as to assess resectability of pancreatic cancer. Usually morphologic changes of chronic pancreatitis result in a shrunken and atrophic pancreas, but occasionally it may present as a mass-forming FP and thus may mimic a PC (12) . This may lead to a difficult preoperative differential diagnosis. Recent technical innovations have introduced diffusionweighted MR imaging with apparent diffusion coefficient (ADC) measurements. The usefulness of DWI with a singleshot spin-echo echo-planar sequence (EPI) for the evaluation of neoplastic diseases in the abdominal region has been reported by several studies (4, 8, 19) .
However, measured abdominal ADC values depend on the exact selection of b values, in addition ADC values also depend on the field strength of the scanner (20) . There is a consistent decrease of ADC values with increased diffusion weighting as well as with increased field strength. This might partially explain the variations of ADC values for PC according to previous reports. Also the use of a thin slice thickness of 2.6 mm for the DWI imaging and the use of two b values as compared to the use multiple b values have influenced the ADC measurements. However, the use of a the thin slice thickness and two b values did allow a rapid acquisition of images, albeit at a low signal to noise ratio (SNR) of DWI images and thus influencing the ADC values. PC has been associated with decreased ADC values compared to healthy pancreatic tissue due to the presence of fibrosis and increased cellularity which is associated with restricted water diffusion (13) . Necrosis is a common feature of PC and is associated with increased ADC values due to increased motion of the water protons in the tissue (21) . Inflammation within and/ or surrounding the PC is also a common feature of larger PC; this is due to the obstruction of the pancreatic duct or its side branches (22, 23) . Inflammatory processes correlate with an increase of water diffusions, and thus have increased ADC values (14) . Yoshikawa et al. found significantly increased ADC values for PC compared to ADC values for healthy pancreas parenchyma (18) . Similarly, we found increased ADC values for PC and mass-forming FP compared to the pancreatic gland in the control group. This might be due to the large lesions sizes (PC and massforming FP) in our study compared to previous studies, as these larger lesions are more commonly associated with necrosis and inflammation. ADC values for the massforming FP also proved to be significantly higher compared with those of the normal pancreatic tissue. However, there was a significant overlap in ADC values for PC and massforming FP, with the consequent problem of their correct differentiation. Chronic pancreatitis can also contain areas of fibrosis and focal inflammatory reactions (12) , which might explain the difficulty to differentiate these severe pancreatic lesions.
This study has some limitations, such as that the average age of the patients was significantly higher than that of our healthy controls. This might have independently influenced the measured ADC, however, the age range for the two patient groups was comparable. Second, the patient and control group were relatively small. Thus a statistically significant difference in ADC values might be established in a larger sample. An additional limitation is that we only analyzed the quantitative information of ADC maps, leaving aside the qualitative information of the obtained DWI images (24) . Thus, we only evaluated the value of ADC in differentiating PC, mass-forming FP, and normal pancreas from each other. The additional information of the original images with different b values has not been used and the value of DWI in the detection and differentiation has not been analyzed. Furthermore, we did not evaluate ADC values of adjacent pancreas parenchyma surrounding the lesion, which could have also yielded extra information. Finally, the ROIs to acquire ADC values covered the whole lesion including central necrosis. These larger ROIs were used, to make the method feasible in the daily clinical routine; however this might have biased the measurement of ADCs in the patient group.
In conclusion, we could not demonstrate that using ADC measurements of focal pancreatic lesions is a viable 
